PPLPHARMA · Health Care · 2026-08-07

Piramal Pharma Ltd

8.2★★★ PrimeStrong +12.7Stage 2 · wk 4In scan: Breakout WatchMARKET: BULL TOPPING · 2026-08-07
₹209.6
+0.63% today
₹27,766 Cr · Large cap
About this companyHealth Care· Pharmaceuticals
Expand ▾

Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; offers inhalation anesthetics, intrathecal therapy, injectable pain and anesthesia drugs, and other generic and specialty products; and analgesics, skin care, vitamin/mineral supplement, kids' wellness, digestives, women's health, and hygiene, as well as adult incontinence. The company was incorporated in 2020 and is based in Mumbai, India.

Visit company website →
ROE
-4.0%
Profit margin -3.7%
Dividend Yield
0.08%
P/B 2.9
vs 52W High
0.0%
₹133.3 lo₹209.6 hi
Near 52W high
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 4
1w13w26w
Week 4 — early Stage 2, building
How long this stock has been in Stage 2. The sweet spot is typically 13–26 weeks — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
22.8%
200 DMA: ₹170.7 · sloping down
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.56x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↑ ⇈
Accelerating · MA20 +8.1% vs MA50 +3.6% / 10d
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Health Care
↑ Building
Stage 2%
51.6%
20d Δ
+1.6pp
1M return
+3.1%
3M return
+11.6%
Sector Stage-2 % · last 20 days
This stock ranks #53 of 79 Stage 2 stocks in Health Care by RS.
Industry
Pharmaceuticals
→ Flat
Stage 2%
50.5%
20d Δ
+0.5pp
1M return
+1.9%
3M return
+11.7%
Industry Stage-2 % · last 20 days
Ranks #35 of 53 Stage 2 stocks in this industry.
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2023-05-15 → 2026-08-07
S2 18w
S2 38w
S4 20w
S4 23w
2023-05-152026-08-07
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 12w → S1 2w → S2 8w → S3 3w → S2 18w → S3 7w → S2 38w → S3 9w → S4 7w → S1 3w → S4 20w → S1 4w → S4 23w → S1 9w → S2 3w current
Total tracked: 168 weeks across 15 stage runs.
1M
+21.8%
3M
+16.5%
6M
+35.1%
YTD
+21.2%
1Y
+4.1%
Scan Membership
Breakout Watch
Latest: 2026-07-16
2 appearances in last 60 days. First seen: 2024-05-03.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-08-07S2
Wk 4 · Vol —x
2026-08-06S2
Wk 4 · Vol —x
2026-08-05S2
Wk 3 · Vol —x
2026-08-04S2
Wk 3 · Vol —x
2026-08-03S2
Wk 3 · Vol —x
2026-07-31S2
Wk 3 · Vol —x
2026-07-30S2
Wk 3 · Vol —x
2026-07-29S2
Wk 2 · Vol —x
2026-07-28S2
Wk 2 · Vol —x
2026-07-27S2
Wk 2 · Vol —x
2026-07-24S2
Wk 2 · Vol —x
2026-07-23S2
Wk 2 · Vol —x
Sector Peers — Stage 2All →
DIVISLAB
wk 12 · -3.6% from hi
8.5
LAURUSLABS
wk 16 · -0.3% from hi
8.4
LALPATHLAB
wk 9 · 0.0% from hi
7.9
SHILPAMED
wk 13 · 0.0% from hi
7.8
BALPHARMA
wk 9 · -9.6% from hi
7.6
Moving averages & range
50 DMA
₹176.2
200 DMA
₹170.7
52W High
₹209.6
52W Low
₹133.3
5D Low
₹199.3
Resistance levels (recent highs)
20d High
₹209.6
60d High
₹209.6
120d High
₹209.6
250d High
₹209.6
Next resistance
Above all

All analytics based on EOD data. Data as of 2026-08-07. Past data patterns are not indicative of future results. This page is a data analytics tool only.